Movement Alert|Medpace Holdings Rises 7.2% in Regular Trading, Trading at $507.6

Market Focus06-25

On June 24, Medpace Holdings rose 7.2% in regular trading, trading at $507.6 USD/share, with Turnover of $90.19 million.

Within the Life Sciences Tools & Services sector where Medpace Holdings belongs, the overall sector showed broad strength. Among individual stocks, Icon PLC up 12.34%, Illumina up 6.33%, Danaher up 4.9%, Mettler-Toledo up 4.38%, Thermo Fisher Scientific up 3.98%.

Medpace Holdings is a global leading clinical contract research organization (CRO), specializing in science-driven outsourced clinical development services for the biotechnology, pharmaceutical, and medical device industries, covering Phase I through Phase IV clinical development with particular strength in oncology, metabolic diseases, and cardiology.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment